Stephen Carter

Filings by Stephen Carter span 3 companies, the busiest being Cytogen Corp, Vion Pharmaceuticals Inc and Alfacell Corp. Over a trading history stretching from 30 December 2005 to 8 May 2008, the count stands at 5 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

Most recently, on 12 May 2008, the filings show a transaction in Cytogen Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.